Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Lancet Infect Dis

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    October 2018
  1. KISSINGER P, Muzny CA, Mena LA, Lillis RA, et al
    Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Lancet Infect Dis. 2018 Oct 5. pii: S1473-3099(18)30423.
    PubMed     Text format     Abstract available


  2. HUGHES G, Fifer H
    Point-of-care tests for chlamydia and gonorrhoea in Indigenous communities.
    Lancet Infect Dis. 2018;18:1054-1055.
    PubMed     Text format    


    September 2018
  3. DIVALA TH, Mungwira RG, Mawindo PM, Nyirenda OM, et al
    Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Lancet Infect Dis. 2018 Sep 5. pii: S1473-3099(18)30415.
    PubMed     Text format     Abstract available


    August 2018
  4. ADENIS AA, Valdes A, Cropet C, McCotter OZ, et al
    Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.
    Lancet Infect Dis. 2018 Aug 23. pii: S1473-3099(18)30354.
    PubMed     Text format     Abstract available


  5. BURKI T
    The USA's HIV problem.
    Lancet Infect Dis. 2018;18:840-841.
    PubMed     Text format    


    July 2018
  6. SAGARA I, Healy SA, Assadou MH, Gabriel EE, et al
    Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
    Lancet Infect Dis. 2018 Jul 27. pii: S1473-3099(18)30344.
    PubMed     Text format     Abstract available


  7. WOODHALL SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, et al
    Advancing the public health applications of Chlamydia trachomatis serology.
    Lancet Infect Dis. 2018 Jul 5. pii: S1473-3099(18)30159.
    PubMed     Text format     Abstract available


  8. NKENGASONG JN, Mbopi-Keou FX, Peeling RW, Yao K, et al
    Laboratory medicine in Africa since 2008: then, now, and the future.
    Lancet Infect Dis. 2018 Jul 3. pii: S1473-3099(18)30120.
    PubMed     Text format     Abstract available


  9. KALLA GCM, Voundi EV, Angwafo F 3rd, Belec L, et al
    Mass screening for hepatitis B and C and HIV in sub-Saharan Africa.
    Lancet Infect Dis. 2018;18:716.
    PubMed     Text format    


    June 2018
  10. ZAID M, Afzal MS
    HIV outbreak in Pakistan.
    Lancet Infect Dis. 2018;18:601.
    PubMed     Text format    


    May 2018
  11. MENDELSON M, Hamer DH
    Out of the frying pan and into the fire.
    Lancet Infect Dis. 2018 May 17. pii: S1473-3099(18)30244.
    PubMed     Text format    


  12. SEEDAT F, Hargreaves S, Nellums LB, Ouyang J, et al
    How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Lancet Infect Dis. 2018 May 16. pii: S1473-3099(18)30117.
    PubMed     Text format     Abstract available


    April 2018
  13. VARIAVA E, Martinson N
    Drug-resistant tuberculosis: the rise of the monos.
    Lancet Infect Dis. 2018 Apr 20. pii: S1473-3099(18)30247.
    PubMed     Text format    


  14. MENDELSON M, Brink A, Gouws J, Mbelle N, et al
    The One Health stewardship of colistin as an antibiotic of last resort for human health in South Africa.
    Lancet Infect Dis. 2018 Apr 16. pii: S1473-3099(18)30119.
    PubMed     Text format     Abstract available


  15. LABORDE-BALEN G, Taverne B, Ndour CT, Kouanfack C, et al
    The fourth HIV epidemic.
    Lancet Infect Dis. 2018;18:379-380.
    PubMed     Text format    


    March 2018
  16. WALZL G, McNerney R, du Plessis N, Bates M, et al
    Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.
    Lancet Infect Dis. 2018 Mar 23. pii: S1473-3099(18)30111.
    PubMed     Text format     Abstract available


  17. FIFER H, Cole M, Hughes G, Padfield S, et al
    Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.
    Lancet Infect Dis. 2018 Mar 6. pii: S1473-3099(18)30122.
    PubMed     Text format     Abstract available


  18. BOYLES T
    Xpert Ultra's place in the diagnosis of tuberculous meningitis.
    Lancet Infect Dis. 2018;18:248-249.
    PubMed     Text format    


    February 2018
  19. FERLAZZO G, Mohr E, Laxmeshwar C, Hewison C, et al
    Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.
    Lancet Infect Dis. 2018 Feb 13. pii: S1473-3099(18)30100.
    PubMed     Text format     Abstract available


  20. KOUDOU BG, de Souza DK, Biritwum NK, Bougma R, et al
    Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?
    Lancet Infect Dis. 2018 Feb 2. pii: S1473-3099(18)30069.
    PubMed     Text format     Abstract available


  21. COLEMAN BW, Sereti I, Bishop R, Smith BR, et al
    Upbeat nystagmus in an HIV-positive patient with a tuberculoma in the medulla.
    Lancet Infect Dis. 2018;18:225.
    PubMed     Text format    


  22. ASSEFA Y
    Expansion of the WHO public health approach to HIV.
    Lancet Infect Dis. 2018;18:143-144.
    PubMed     Text format    


    January 2018
  23. DESAI M, Hill J, Fernandes S, Walker P, et al
    Prevention of malaria in pregnancy.
    Lancet Infect Dis. 2018 Jan 30. pii: S1473-3099(18)30064.
    PubMed     Text format     Abstract available


  24. MCCLELLAND RS, Lingappa JR, Srinivasan S, Kinuthia J, et al
    Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.
    Lancet Infect Dis. 2018 Jan 25. pii: S1473-3099(18)30058.
    PubMed     Text format     Abstract available


  25. PASSMORE JS, Jaspan HB
    Vaginal microbes, inflammation, and HIV risk in African women.
    Lancet Infect Dis. 2018 Jan 25. pii: S1473-3099(18)30061.
    PubMed     Text format    


  26. VAN LAARHOVEN A, Dian S, Aguirre-Gamboa R, Avila-Pacheco J, et al
    Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.
    Lancet Infect Dis. 2018 Jan 23. pii: S1473-3099(18)30053.
    PubMed     Text format     Abstract available


  27. DARA M, Zachariah R
    Ending tuberculosis calls for leaving no one behind.
    Lancet Infect Dis. 2018 Jan 8. pii: S1473-3099(17)30746.
    PubMed     Text format    


  28. ZOU H, Tucker JD, Fan S, Xu J, et al
    Learning about HIV the hard way: HIV among Chinese MSM attending university.
    Lancet Infect Dis. 2018;18:16-18.
    PubMed     Text format    


    December 2017
  29. MOLINA JM, Charreau I, Chidiac C, Pialoux G, et al
    Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Lancet Infect Dis. 2017 Dec 8. pii: S1473-3099(17)30725.
    PubMed     Text format     Abstract available



  30. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
    Lancet Infect Dis. 2017 Dec 6. pii: S1473-3099(17)30703.
    PubMed     Text format     Abstract available


    November 2017
  31. YERLY S, Calmy A
    Time to overcome pretreatment HIV drug resistance.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30709.
    PubMed     Text format    


  32. DORMAN SE, Schumacher SG, Alland D, Nabeta P, et al
    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30691.
    PubMed     Text format     Abstract available


  33. GUPTA RK, Gregson J, Parkin N, Haile-Selassie H, et al
    HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30702.
    PubMed     Text format     Abstract available


  34. LIN C, Franceschi S, Clifford GM
    Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30653.
    PubMed     Text format     Abstract available


  35. HERMANS LE, Moorhouse M, Carmona S, Grobbee DE, et al
    Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30681.
    PubMed     Text format     Abstract available


  36. CASTAGNA A, Galli L
    Stepping up HIV-1 low-level viraemia surveillance in South Africa.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30680.
    PubMed     Text format    


  37. ZELENEV A, Li J, Mazhnaya A, Basu S, et al
    Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Lancet Infect Dis. 2017 Nov 15. pii: S1473-3099(17)30676.
    PubMed     Text format     Abstract available


  38. HILL AM, Venter F
    The unexpected success of NRTIs in second-line treatment.
    Lancet Infect Dis. 2017 Nov 3. pii: S1473-3099(17)30631.
    PubMed     Text format    


  39. HAKIM JG, Thompson J, Kityo C, Hoppe A, et al
    Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
    Lancet Infect Dis. 2017 Nov 3. pii: S1473-3099(17)30630.
    PubMed     Text format     Abstract available


  40. COUSINS S
    HIV and antenatal care in Sri Lanka: a global health success.
    Lancet Infect Dis. 2017;17:1126.
    PubMed     Text format    


    October 2017
  41. ABEL L, Fellay J, Haas DW, Schurr E, et al
    Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives.
    Lancet Infect Dis. 2017 Oct 27. pii: S1473-3099(17)30623.
    PubMed     Text format     Abstract available


  42. FORD N, Ball A, Baggaley R, Vitoria M, et al
    The WHO public health approach to HIV treatment and care: looking back and looking ahead.
    Lancet Infect Dis. 2017 Oct 20. pii: S1473-3099(17)30482.
    PubMed     Text format     Abstract available


  43. CAMBIANO V, Miners A, Dunn D, McCormack S, et al
    Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
    Lancet Infect Dis. 2017 Oct 17. pii: S1473-3099(17)30540.
    PubMed     Text format     Abstract available


  44. REVILL P, Dwyer E
    Pre-exposure prophylaxis is cost-effective for HIV in the UK.
    Lancet Infect Dis. 2017 Oct 17. pii: S1473-3099(17)30594.
    PubMed     Text format    


    September 2017
  45. BEIGEL JH, Bao Y, Beeler J, Manosuthi W, et al
    Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
    Lancet Infect Dis. 2017 Sep 22. pii: S1473-3099(17)30476.
    PubMed     Text format     Abstract available


  46. BAHR NC, Nuwagira E, Evans EE, Cresswell FV, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.
    Lancet Infect Dis. 2017 Sep 14. pii: S1473-3099(17)30474.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: